Exhibit 107
Calculation of Filing Fee Tables
Schedule 13E-3
(Form Type)
GreenLight Biosciences Holdings, PBC
(Exact Name of Registrant as Specified in its Charter)
Table 1 - Transaction Value
| Transaction Valuation | Fee Rate | Amount of Filing Fee | ||||
Fees to Be Paid | $9,348,082.80 (1) | .0001102 | $1,030.16(2) | |||
Fees Previously Paid | $— | $— | ||||
Total Transaction Valuation | $9,348,082.80 | |||||
Total Fees Due for Filing | $1,030.16 | |||||
Total Fees Previously Paid | $— | |||||
Total Fee Offsets | $1,030.16 | |||||
Net Fee Due | $0.00 | |||||
Table 2 - Fee Offset Claims and Sources
Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Fee Paid with Fee Offset Source | ||||||||
Fee Offset Claims | Schedule TO-T | 005-92011 | June 21, 2023 | 2,166.25 (3) | ||||||||||
Fee Offset Sources | GreenLight Biosciences Holdings, PBC | Schedule TO-T | 005-92011 | June 21, 2023 | 2,166.25 (3) | |||||||||
| (1) | Estimated solely for the purpose of calculating the filing fee pursuant to Rule 0-11(d) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Transaction Valuation was calculated by multiplying (A) 31,160,276, which is the total number of shares of common stock of GreenLight Biosciences Holdings, PBC. outstanding (“Shares”) not beneficially owned by certain existing holders of GreenLight Biosciences Holdings, PBC who each entered into a Contribution and Exchange Agreement with SW ParentCo, Inc. concurrently with that certain Merger Agreement dated as of May 29, 2023 (calculated as the difference between 151,681,314, the total number of outstanding Shares and 120,521,038, the number of Shares beneficially owned by the Rollover Shareholders as of the date hereof) by (B) $0.30, which is the per Share tender offer price. The calculation of the Transaction Valuation is based on information provided as of June 14, 2023, the most recent practicable date. |
| (2) | The amount of the filing fee, calculated in accordance with Rule 0-11(a)(2) of the Exchange Act was calculated by multiplying $9,348,082.80 by 0.0001102. |
| (3) | $2,166.25 was previously paid upon the filing of a Schedule TO-T on June 21, 2023, in connection with the transaction reported hereby. |
